Trotabresib is an inhibitor of bromodomain-containing protein 4 (BRD4; IC50 = ≤0.5 ?M).1 It inhibits the proliferation of Raji Burkitt’s lymphoma and HL-60 leukemia cells (IC50 = ≤0.5 ?M for both).
1.Betancort, J.M., Stafford, J.A., Stansfield, R., et al.Bromodomain inhibitor(2016)
















